Biblio Discovery — Demo Discovery Service

11 results for "Timothy An-thy Chan"

Showing 1–11 · 0.45 seconds · RSS

  1. Journal Article

    COVID-19 and Cardiovascular Disease

    Mina K. Chung; David A. Zidar; Michael R. Bristow et al.

    Circulation Research · 2021 · English · OpenAlex Scopus

    A pandemic of historic impact, coronavirus disease 2019 (COVID-19) has potential consequences on the cardiovascular health of millions of people who survive infection worldwide. Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), the etiologic agent of COVID-19, can infect the heart…

  2. Journal Article

    Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers

    Matteo Palmeri; Janice M. Mehnert; Ann Willman Silk et al.

    ESMO Open · 2021 · English · OpenAlex Scopus

    INTRODUCTION: Microsatellite instability (MSI) testing and tumor mutational burden (TMB) are genomic biomarkers used to identify patients who are likely to benefit from immune checkpoint inhibitors. Pembrolizumab was recently approved by the Food and Drug Administration for use in TMB-high (TMB-H)…

  3. Journal Article Full text

    HIF-1α and HIF-2α differently regulate tumour development and inflammation of clear cell renal cell carcinoma in mice

    Rouven Hoefflin; Sabine Harlander; Silvia Schäfer et al.

    Nature Communications · 2020 · English · OpenAlex Scopus

    …functional studies using human ccRCC cell lines have implicated HIF-1α as an inhibitor and HIF-2α as a promoter of aggressive tumour behaviours, their roles in tumour onset have not been functionally addressed. Herein we show using an autochthonous ccRCC model that Hif1a is essential for tumour…

  4. Journal Article Full text

    Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors

    Cristina Valero; Mark Andrew Lee; Douglas Robert Hoen et al.

    Nature Communications · 2021 · English · OpenAlex Scopus

    Treatment with immune checkpoint inhibitors (ICI) has demonstrated clinical benefit for a wide range of cancer types. Because only a subset of patients experience clinical benefit, there is a strong need for biomarkers that are easily accessible across diverse practice settings. Here, in a…

  5. Journal Article

    Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment Selection

    Wungki Park; Jiapeng Chen; Joanne F. Chou et al.

    Clinical Cancer Research · 2020 · English · OpenAlex Scopus

    Abstract Purpose: Genomic methods can identify homologous recombination deficiency (HRD). Rigorous evaluation of their outcome association to DNA damage response–targeted therapies like platinum in pancreatic ductal adenocarcinoma (PDAC) is essential in maximizing therapeutic outcome. Experimental…

  6. Journal Article Full text

    Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

    Lorenzo Galluzzi; Ilio Vitale; Sarah Warren et al.

    Journal for ImmunoTherapy of Cancer · 2020 · English · OpenAlex Scopus

    Cells succumbing to stress via regulated cell death (RCD) can initiate an adaptive immune response associated with immunological memory, provided they display sufficient antigenicity and adjuvanticity. Moreover, multiple intracellular and microenvironmental features determine the propensity of RCD…